A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)

Summary

The aim of this protocol is to investigate a novel form of immune therapy for patients with acute myelogenous leukemia (AML) who are in remission (CR) but who are at high risk for relapse.

Timeline

Start

2010-01

Primary completion

2013-06

Completion

2013-06

Outcome

Outcome not reported

Stopped (Enrollment): “lack of accrual”

Drugs

Indications